Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-28

FDA Approved: NAFTIFINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a Sun Pharmaceutical supplemental application for Naftifine Hydrochloride, updating the product labeling for the topical antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naftifine hydrochloride (Naftifine hydrochloride)

Snippet

SUPPL AP for NAFTIFINE HYDROCHLORIDE (NAFTIFINE HYDROCHLORIDE)